Literature DB >> 2002451

Tetrahydropyridyloxadiazoles: semirigid muscarinic ligands.

G A Showell1, T L Gibbons, C O Kneen, A M MacLeod, K Merchant, J Saunders, S B Freedman, S Patel, R Baker.   

Abstract

Recent studies have described novel azabicycle-based muscarinic agonists which readily penetrate into the central nervous system and are capable of displaying high efficacy at cortical sites. The current paper describes the synthesis and biochemical assessment of semirigid muscarinic ligands which were used to map the requirements of the cortical muscarinic receptor and to study the degree of conformational flexibility required to cause receptor activation. Analogues 6 and 9 provide high-efficacy muscarinic agonists at cortical sites; however, C-alkylation on the tetrahydropyridine ring resulted in more rigid analogues and showed lower predicted efficacy. Molecular mechanics calculations indicated a preference for the E rotameric form. This conformation was also observed in the X-ray crystal structure of ethenyloxadiazole 12. The new compounds were tested in a biochemical assay designed to measure receptor affinity and to predict cortical efficacy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002451     DOI: 10.1021/jm00107a032

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.

Authors:  H Bourdon; S Trumpp-Kallmeyer; H Schreuder; J Hoflack; M Hibert; C G Wermuth
Journal:  J Comput Aided Mol Des       Date:  1997-07       Impact factor: 3.686

2.  Synthesis of phidianidines A and B.

Authors:  Hong-Yu Lin; Barry B Snider
Journal:  J Org Chem       Date:  2012-05-01       Impact factor: 4.354

3.  Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.

Authors:  D J Triggle; Y W Kwon; P Abraham; M A Rahman; F I Carroll
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

4.  5-(2,4-Dichloro-phen-yl)-3-(4-nitro-phen-yl)-1,2,4-oxadiazole.

Authors:  Hoong-Kun Fun; Mohd Mustaqim Rosli; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-28

5.  3-(2,4-Dichloro-phen-yl)-5-methyl-1,2,4-oxadiazole.

Authors:  Hoong-Kun Fun; Mohd Mustaqim Rosli; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-06

6.  2,5-Bis(4-meth-oxy-phen-yl)-1,3,4-oxadiazole.

Authors:  Hoong-Kun Fun; Jia Hao Goh; B Kalluraya
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-06

7.  3-(2,4-Dichloro-phen-yl)-5-phenyl-1,2,4-oxadiazole.

Authors:  Hoong-Kun Fun; Mohd Mustaqim Rosli; Sankappa Rai; Arun M Isloor; Prakash Shetty
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-03-17

8.  Benzyl N-{2-[5-(4-chloro-phen-yl)-1,2,4-oxadiazol-3-yl]propan-2-yl}carbamate.

Authors:  Hoong-Kun Fun; V Sumangala; G K Nagaraja; Boja Poojary; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-15

9.  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Gail Winger; Jack Bergman; Andrew Coop; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2021-03-12       Impact factor: 4.402

10.  SET activation of nitroarenes by 2-azaallyl anions as a straightforward access to 2,5-dihydro-1,2,4-oxadiazoles.

Authors:  Dong Zou; Lishe Gan; Fan Yang; Huan Wang; Youge Pu; Jie Li; Patrick J Walsh
Journal:  Nat Commun       Date:  2021-12-03       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.